Latest Headlines

  1. Labcorp Announces Acquisition Of Select Assets Of BioReference Health's Innovative Oncology And Related Clinical Testing Services Businesses 3/11/2025

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.

  2. Pramana And ARUP Laboratories Partner To Digitize Pathology Slides And Develop AI-Powered Hematopathology Algorithms For Deployment Via Edge AI 3/11/2025

    Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and ARUP Laboratories, the largest nonprofit clinical and academic reference laboratory in the United States, announced a collaboration to digitize pathology slides and develop AI-powered algorithms to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology.

  3. Augurex Announces UK Conformity Assessed (UKCA) Authorization For JOINTstat, Expanding Access To Cutting-Edge Rheumatoid Arthritis Testing In Great Britain 3/10/2025

    Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced that JOINTstat, the Company’s blood test for 14-3-3eta, has received UK Conformity Assessed (UKCA) marking.

  4. Beckman Coulter Announces FDA Clearance Of DxC 500i Clinical Analyzer, An Integrated Clinical Chemistry And Immunoassay System 3/10/2025

    Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the U.S. Food and Drug Administration.

  5. QuidelOrtho Introduces Results Manager System 3/10/2025

    QuidelOrtho Corporation (“QuidelOrtho”) announces the availability of the QuidelOrtho Results Manager System, an informatics solution designed to address the growing demands of modern laboratories.

  6. ARUP Laboratories Expands AI-Augmented Parasitology Screening Tool, Improves Detection And Diagnosis 3/6/2025

    ARUP Laboratories announced today the expansion of its groundbreaking AI-augmented screening tool for the detection of human gastrointestinal parasites to include wet-mount slides.

  7. Savara Announces U.S. Launch Of The aPAP ClearPath Dried Blood Spot Test To Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP) 3/6/2025

    Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the launch of the aPAP ClearPath Dried Blood Spot (DBS) Test in the U.S., an evolution of the first serum-based assay the Company launched.

  8. Newly-Formed Archerfish Precision Diagnostics Pte Ltd: Ushers A New Era In Advanced Diagnostics 3/6/2025

    In a significant development for the clinical diagnostics landscape in Singapore, Angsana Molecular & Diagnostics Laboratory (Angsana) and Pathnova Laboratories (Pathnova) have announced their merger to form Archerfish Precision Diagnostics Private Limited (Archerfish).

  9. Breakthrough CRISPR-Based Test Offers Faster, More Accurate Diagnosis For Fungal Pneumonia 3/5/2025

    Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) — a life-threatening fungal infection primarily affecting children and immunocompromised patients — more quickly and less invasively, according to a new study published in the Journal of Clinical Investigation.

  10. Epredia Receives U.S. FDA 510(K) Clearance For The E1000 Dx Digital Pathology Solution Designed To Improve Laboratory Workflow In Cancer Diagnostics 3/4/2025

    Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation today announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 Dx Digital Pathology Solution (E1000 Dx).